Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News ABVC Biopharma Inc ABVC

Healthcare Biotechnology
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on development products and technologies to combat various diseases. The Company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. It has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ABVC)

ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones

GlobeNewswire 10 days ago

ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners

GlobeNewswire October 22, 2024

ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements

GlobeNewswire August 15, 2024

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

GlobeNewswire April 18, 2024

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

GlobeNewswire April 17, 2024

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M

GlobeNewswire April 10, 2024

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M

GlobeNewswire March 26, 2024

AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars

GlobeNewswire March 21, 2024

ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine

GlobeNewswire March 19, 2024
View More News ››

Opinion & Analysis (NDAQ:ABVC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ABVC)

ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and O

NEWS: $ABVC ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational MilestonesABVC BioPharma Achieved its First...
whytestocks - 10 days ago

ABVC BioPharma, Inc. (NASDAQ: ABVC): A Promising Biopharmace

http://beyondspx.com/2024/07/31/abvc-biopharma-inc-nasdaq-abvc-a-promising-biopharmaceutical-player-navigating-the-ophthalmology-cns-and...
MikeTester - August 2, 2024

Immunity Boosting Combination Therapy for Myelodysplastic Sy

NEWS: $ABVC Immunity Boosting Combination Therapy for Myelodysplastic Syndrome (pre-Leukemia) Treatment: A Milestone Collaboration...
whytestocks - May 24, 2024

US Companies Moving the Markets, Evening edition <br>Tue, Ap

JUST IN: $ABVC US Companies Moving the Markets, Evening edition Tue, Apr 23, 2024 as of 4:00 pm ETA look at the top 10 most actives in...
whytestocks - April 23, 2024

ABVC.....Let the bleeding continue

Sheesh
Iseneschal - March 26, 2024

RE:ABVC.....Early a.m runner on NR

Reading what a few are saying about ABVC ....... every PR this company puts out is a deal with some company you can’t do any DD on
Iseneschal - March 26, 2024
View more Bullboard ››

NexTech3D.AI Corp.

NexTech3D.AI Corp.

NexTech3D.AI Corp. is a diversified augmented reality (AR), artificial intelligence (AI) technology company. The Company ...
View More »